(NASDAQ: ALZN) Alzamend Neuro's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.27%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 70.78%.
Alzamend Neuro's earnings in 2025 is -$4,280,588.On average, 1 Wall Street analyst forecast ALZN's earnings for 2025 to be -$8,708,709, with the lowest ALZN earnings forecast at -$8,708,709, and the highest ALZN earnings forecast at -$8,708,709.
In 2026, ALZN is forecast to generate -$11,149,787 in earnings, with the lowest earnings forecast at -$11,149,787 and the highest earnings forecast at -$11,149,787.